McGill bioethicists argue for stricter limits on first-in-human clinical trials

The standards for drugs entering first-in-human (FIH) clinical trials are too low, argues Associate Professor Dr. Jonathan Kimmelman and PhD candidate Carole Federico in McGill’s Biomedical Ethics Unit. In a commentary published online in Nature on Jan. 30, Kimmelman and Federico maintain that evidence for drug efficacy is not emphasized enough before[Read More…]

McGill takes the stage at Davos

From Jan. 17 to 20, McGill Principal and Vice-Chancellor Suzanne Fortier attended the World Economic Forum (WEF) in Davos, Switzerland to discuss labour markets for post-secondary graduates and to present research on sustainability and global connectivity. Fortier was accompanied by Professor Andrew Gonzalez of the Department of Biology, Assistant Professor[Read More…]

Spousal hiring at McGill

A professor, who is remaining anonymous, was previously a faculty lecturer at McGill University. From her perspective, she had done everything that was expected of a good academic. She had good student reviews, published papers, and made presentations at international conferences. So when she was suddenly told that McGill would[Read More…]

Read the latest issue

Read the latest issue